(Q35036182)

5 August 2017

1 reference

title

Possible pathogenic mechanisms in inflammatory myopathies (English)

1 reference

5 August 2017

1

Ingrid E Lundberg

1 reference

5 August 2017

Maryam Dastmalchi

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Rheumatic Diseases Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

28

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

799-822

1 reference

Polymyositis, dermatomyositis and inclusion-body myositis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Microvascular changes in early and advanced dermatomyositis: a quantitative study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

The immunobiology of muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Lymphotoxin formation by lymphocytes and muscle in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

T cell receptor beta-chain repertoire in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Limited T-cell receptor V gene usage in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Polymyositis mediated by T lymphocytes that express the gamma/delta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

T cell receptor repertoire in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Molecular genetic studies of major histocompatibility complex genes in children with Juvenile dermatomyositis: Increased risk associated with HLA-DQA1∗0501

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Update on the genetics of the idiopathic inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Update on immunopathogenesis in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of immunoreactive major histocompatibility complex products in human skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of class I and class II MHC antigens in neuromuscular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of HLA-DR and its enhancing molecules in muscle fibers in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Immunological capabilities of skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Pathogenesis of neuroimmunologic diseases. Experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Autoimmune recognition of cartilage collagens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

The inhibition of apoptosis in myositis and in normal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Cell death and oxidative damage in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of human IAP-like protein in skeletal muscle: a possible explanation for the rare incidence of muscle fiber apoptosis in T-cell mediated inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

T-cell anti-apoptotic mechanisms in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Calpain and cathepsins in the skeletal muscle of inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Local T-cell proliferation and differentiation in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Immunofluorescent evidence for presence of interleukin-1 in normal and diseased human skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Cytokine expression profile in idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Microvascular deposition of complement membrane attack complex in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Endothelial inclusions in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Vascular Deposits of Immunoglobulin and Complement in Idiopathic Inflammatory Myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Expression of cell adhesion molecules in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

High endothelial venules (HEVs): specialized endothelium for lymphocyte migration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Update on myositis-specific and myositis-associated autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Myositis-specific autoantibodies: overview and recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Myositis induced by naked DNA immunization with the gene for histidyl-tRNA synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Structure and function of signal recognition particle (SRP).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Antibody to signal recognition particle in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Autoantibody profiles in the sera of European patients with myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Altered energy utilization during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Dermatomyositis: correlative MR imaging and P-31 MR spectroscopy for quantitative characterization of inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Muscle hypoxia in myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Interleukin-1? expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: Important pathogenic features independent of inflammatory cell clusters in muscl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Influence of hypoxia in inflammatory synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Interleukin-1 expression in normal motor endplates and muscle fibers showing neurogenic changes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

The early effects of ischemia upon skeletal muscle mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Cytokines block the effects of insulin-like growth factor-I (IGF-I) on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Proinflammatory cytokines regulate myogenic cell proliferation and fusion but have no impact on myotube protein metabolism or stress protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Effect of tumor necrosis factor-alpha on skeletal muscle metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

1 reference

7 January 2021

Human leukocyte antigen class I in polymyositis: leukocyte infiltrates, regeneration, and impulse block

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Denervation enhances spontaneous inflammatory myopathy in SJL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Inclusion body myositis, a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Inclusion body myositis (IBM): Myopathy or neuropathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Inclusion body myositis: genetic factors, aberrant protein expression, and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Inclusion body myositis and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Production of IL-6 by human myoblasts stimulated with Abeta: relevance in the pathogenesis of IBM

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Polymyositis and dermatomyositis (second of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900025-X

7 January 2021

10.1016/S0889-857X(02)00025-X

Identifiers

DOI

1 reference

5 August 2017

1 reference